These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 18640459)

  • 1. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.
    McQueen MJ; Hawken S; Wang X; Ounpuu S; Sniderman A; Probstfield J; Steyn K; Sanderson JE; Hasani M; Volkova E; Kazmi K; Yusuf S;
    Lancet; 2008 Jul; 372(9634):224-33. PubMed ID: 18640459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study.
    Sniderman AD; Islam S; Yusuf S; McQueen MJ
    Atherosclerosis; 2012 Dec; 225(2):444-9. PubMed ID: 23068583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
    Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
    Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
    Stampfer MJ; Sacks FM; Salvini S; Willett WC; Hennekens CH
    N Engl J Med; 1991 Aug; 325(6):373-81. PubMed ID: 2062328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
    Yusuf S; Hawken S; Ounpuu S; Dans T; Avezum A; Lanas F; McQueen M; Budaj A; Pais P; Varigos J; Lisheng L;
    Lancet; 2004 Sep 11-17; 364(9438):937-52. PubMed ID: 15364185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries in a case-control study based on the INTERHEART study].
    Gyárfás I; Keltai M; Salim Y
    Orv Hetil; 2006 Apr; 147(15):675-86. PubMed ID: 16734179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the superiority of apoB over non-HDL-C as a marker of cardiovascular risk in the INTERHEART study due to confounding by related variables?
    Sniderman AD; Islam S; Yusuf S; McQueen MJ
    J Clin Lipidol; 2013; 7(6):626-31. PubMed ID: 24314360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.
    Raitakari OT; Mäkinen VP; McQueen MJ; Niemi J; Juonala M; Jauhiainen M; Salomaa V; Hannuksela ML; Savolainen MJ; Kesäniemi YA; Kovanen PT; Sundvall J; Solakivi T; Loo BM; Marniemi J; Hernesniemi J; Lehtimäki T; Kähönen M; Peltonen M; Leiviskä J; Jula A; Anand SS; Miller R; Yusuf S; Viikari JS; Ala-Korpela M
    Atherosclerosis; 2013 Jan; 226(1):245-51. PubMed ID: 23159013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study.
    Gehani AA; Al-Hinai AT; Zubaid M; Almahmeed W; Hasani MR; Yusufali AH; Hassan MO; Lewis BS; Islam S; Rangarajan S; Yusuf S;
    Eur J Prev Cardiol; 2014 Apr; 21(4):400-10. PubMed ID: 23125402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-high density lipoprotein cholesterol is the best discriminator of myocardial infarction in young individuals.
    Rallidis LS; Pitsavos C; Panagiotakos DB; Sinos L; Stefanadis C; Kremastinos DT
    Atherosclerosis; 2005 Apr; 179(2):305-9. PubMed ID: 15777546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
    Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
    Artery; 1983; 12(1):1-23. PubMed ID: 6431945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction.
    Sewdarsen M; Desai RK; Vythilingum S; Shah N; Rajput MC
    Postgrad Med J; 1991 Feb; 67(784):159-64. PubMed ID: 2041847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
    Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
    Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
    J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study.
    Lamprea-Montealegre JA; Sharrett AR; Matsushita K; Selvin E; Szklo M; Astor BC
    Atherosclerosis; 2014 May; 234(1):42-6. PubMed ID: 24607852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of plasma apolipoprotein B in myocardial infarction in young subjects. Correlations with coronarographic data].
    Douste-Blazy P; Solera ML; Delay M; De Graeve J; Valdiguie P; Marco J; Bernadet P
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):21-6. PubMed ID: 6422890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.